Preclinical Pharmacology of OPC-34712: A Novel Compound with Dopamine D2 Receptor Partial Agonist Activity

被引：0
|
作者：
Kikuchi, Tetsuro [1 ]
Maeda, Kenji [1 ]
Sugino, Haruhiko [1 ]
Akazawa, Hitomi [1 ]
Amada, Naoki [1 ]
Jordan, Shaun [2 ]
Shimada, Jun [1 ]
Yamashita, Hiroshi [1 ]
Ito, Nobuaki [1 ]
Forbes, Robert A. [3 ]
McQuade, Robert D. [3 ]
机构：
[1] Otsuka Pharmaceut Co Ltd, Quest Res Inst, Tokushima 77101, Japan
[2] Otsuka Pharmaceut Co Ltd, Otsuka Maryland Med Labs Inc, Rockville, MD USA
[3] Otsuka Pharmaceut Co Ltd, Otsuka Pharmaceut Dev & Commercializat, Princeton, NJ USA
来源：
BIOLOGICAL PSYCHIATRY | 2011年 / 69卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
320
引用
收藏
页码：95S / 95S
页数：1
相关论文
共 50 条
  • [1] Pharmacology of aripiprazole, a novel antipsychotic:: dopamine D2 receptor partial agonist
    Kikuchi, T
    Arlene, S
    Yocca, F
    Tadori, Y
    Hirose, T
    McQuade, R
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (03) : 190 - 190
  • [2] Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic
    Keck, PE
    McElroy, SL
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (04) : 655 - 662
  • [3] Transformation of a Dopamine D2 Receptor Agonist to Partial Agonists as Novel Antipsychotic Agents
    Liu, Ruiquan
    Qi, Jianzhong
    Wang, Huan
    Fan, Luyu
    Zhang, Pei
    Yu, Jing
    Tan, Liang
    Wang, Sheng
    Cheng, Jianjun
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (09) : 6274 - 6287
  • [4] Aripiprazole acts as a selective dopamine D2 receptor partial agonist
    Wood, Martyn
    Reavill, Charlie
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (06) : 771 - 775
  • [5] Clozapine: partial agonist at dopamine D2 receptors!
    I. Ninan
    S. K. Kulkarni
    [J]. Psychopharmacology, 1998, 138 : 215 - 216
  • [6] Clozapine:: partial agonist at dopamine D2 receptors!
    Ninan, I
    Kulkarni, SK
    [J]. PSYCHOPHARMACOLOGY, 1998, 138 (02) : 215 - 216
  • [7] Bifeprunox:: In vivo characterization of a novel partial agonist for the D2 receptor
    Hesselink, MB
    McCreary, AC
    Glennon, JC
    Marquis, KL
    Hertel, P
    Arnt, J
    Didriksen, M
    Long, SK
    [J]. SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 301 - 301
  • [8] The novel atypical antipsychotic cariprazine demonstrates dopamine D2 receptor-dependent partial agonist actions on rat mesencephalic dopamine neuronal activity
    Delcourte, Sarah
    Ashby, Charles R., Jr.
    Rovera, Renaud
    Kiss, Bela
    Adham, Nika
    Farkas, Bence
    Haddjeri, Nasser
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2018, 24 (12) : 1129 - 1139
  • [9] Aplindore (DAB-452) exhibits high affinity dopamine D2 receptor partial agonist activity
    Pausch, M
    Heinrich, JN
    Lai, M
    Carroll, K
    Homby, G
    Popiolek, M
    Jiang, L
    Stack, G
    Marquis, KL
    Andree, TH
    [J]. SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 308 - 308
  • [10] Identification of a novel dopaminergic agonist that selectively activates the D2 dopamine receptor
    Conroy, Jennie
    Free, R. Benjamin
    Doyle, Trevor B.
    Southall, Noel
    Ferrer, Marc
    Han, Yang
    Javitch, Jonathan A.
    Sibley, David R.
    [J]. FASEB JOURNAL, 2012, 26
12345